CIPLA FDA Approval ANDA 091168

ANDA 091168

CIPLA

FDA Drug Application

Application #091168

Documents

Letter2011-04-01
Letter2018-08-16

Application Sponsors

ANDA 091168CIPLA

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL200MG0EMTRICITABINEEMTRICITABINE

FDA Submissions

ORIG1AP2018-07-02
LABELING; LabelingSUPPL7AP2020-01-22STANDARD

Submissions Property Types

ORIG1Null7
SUPPL7Null7

TE Codes

001PrescriptionAB

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91168
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMTRICITABINE","activeIngredients":"EMTRICITABINE","strength":"200MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EMTRICITABINE","submission":"EMTRICITABINE","actionType":"200MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.